Genetic Landscape of Variants in a Turkish Cohort with GEFS+ Spectrum and Dravet Syndrome

Overview

Journal Mol Syndromol

Date 2022 Sep 26

PMID 36158059

Authors

Ayberk Turkyilmaz

Emine Tekin

Oguzhan Yarali

Alper Han Cebi

Affiliations

Soon will be listed here.

Abstract

Introduction: The α subunit of voltage-gated sodium channels in mammals is encoded by 9 different genes, and variations in the , , , and genes highly expressed in the CNS have been associated with epilepsy phenotypes. This study aimed at investigating the frequency of gene variations in Dravet syndrome (DS) and GEFS+ spectrum phenotype cases and discussing the molecular results in the context of genotype-phenotype correlation.

Methods: Fifteen patients diagnosed with DS and 54 patients meeting the GEFS+ spectrum criteria were included in this study. All patients were evaluated by next-generation sequencing and multiplex ligation-dependent probe amplification using an gene commercial kit.

Results: A total of 17 different variants were detected in 18 index cases (26%), of which 7 were novel variations (p.M1R, p.M147T, p.I767L, p.N1391Ifs*5, p.R1886G, p.E1915G, p.R1933Q). Of the 18 cases with variation in the gene, 12 had DS and 6 had GEFS+ phenotype. The variations were de novo in all DS cases and in 1 case with a GEFS+ phenotype; in 5 GEFS+ cases, the variant was inherited from the affected parent.

Discussion: This study contributes to the variation spectrum in cases with DS and GEFS+ phenotype with the novel variants detected. genetic analysis can help in determining whether antiseizure medication should be selected or avoided in cases with variations. The elucidation of the molecular etiology makes it possible to provide the family with effective genetic counseling for future pregnancies.

Citing Articles

GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics.

Li X, Guo S, Sun Y, Ding J, Chen C, Wu Y J Transl Med. 2024; 22(1):767.

PMID: 39143639 PMC: 11323400. DOI: 10.1186/s12967-024-05387-1.

Identification of five novel variants.

Zeng B, Zhang H, Lu Q, Fu Q, Yan Y, Lu W Front Behav Neurosci. 2023; 17:1272748.

PMID: 38025388 PMC: 10663289. DOI: 10.3389/fnbeh.2023.1272748.

References

WALLACE R, Hodgson B, Grinton B, Gardiner R, Robinson R, Rodriguez-Casero V . Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology. 2003; 61(6):765-9. DOI: 10.1212/01.wnl.0000086379.71183.78. View

Heyne H, Baez-Nieto D, Iqbal S, Palmer D, Brunklaus A, May P . Predicting functional effects of missense variants in voltage-gated sodium and calcium channels. Sci Transl Med. 2020; 12(556). DOI: 10.1126/scitranslmed.aay6848. View

de Lange I, Koudijs M, van t Slot R, Gunning B, Sonsma A, van Gemert L . Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes. Epilepsia. 2018; 59(3):690-703. DOI: 10.1111/epi.14021. View

Fujiwara T . Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies. Epilepsy Res. 2006; 70 Suppl 1:S223-30. DOI: 10.1016/j.eplepsyres.2006.01.019. View

Helbig I . Genetic Causes of Generalized Epilepsies. Semin Neurol. 2015; 35(3):288-92. DOI: 10.1055/s-0035-1552922. View

Zaman T, Helbig K, Clatot J, Thompson C, Kang S, Stouffs K . SCN3A-Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation. Ann Neurol. 2020; 88(2):348-362. PMC: 8552104. DOI: 10.1002/ana.25809. View

Guerrini R, Oguni H . Borderline Dravet syndrome: a useful diagnostic category?. Epilepsia. 2011; 52 Suppl 2:10-2. DOI: 10.1111/j.1528-1167.2011.02995.x. View

Fukuma G, Oguni H, Shirasaka Y, Watanabe K, Miyajima T, Yasumoto S . Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia. 2004; 45(2):140-8. DOI: 10.1111/j.0013-9580.2004.15103.x. View

Escayg A, Heils A, MacDonald B, Haug K, Sander T, Meisler M . A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy. Am J Hum Genet. 2001; 68(4):866-73. PMC: 1275640. DOI: 10.1086/319524. View

10.

Kang K, Kim W, Cho Y, Lee S, Jung K, Shin W . Genetic characteristics of non-familial epilepsy. PeerJ. 2019; 7:e8278. PMC: 6925949. DOI: 10.7717/peerj.8278. View

11.

Malo M, Blanchard B, Andresen J, Srivastava K, Chen X, Li X . Localization of a putative human brain sodium channel gene (SCN1A) to chromosome band 2q24. Cytogenet Cell Genet. 1994; 67(3):178-86. DOI: 10.1159/000133818. View

12.

Goldberg-Stern H, Aharoni S, Afawi Z, Bennett O, Appenzeller S, Pendziwiat M . Broad phenotypic heterogeneity due to a novel SCN1A mutation in a family with genetic epilepsy with febrile seizures plus. J Child Neurol. 2013; 29(2):221-6. DOI: 10.1177/0883073813509016. View

13.

Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O . Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol. 2004; 95:71-102. View

14.

Kivity S, Oliver K, Afawi Z, Damiano J, Arsov T, Bahlo M . SCN1A clinical spectrum includes the self-limited focal epilepsies of childhood. Epilepsy Res. 2017; 131:9-14. DOI: 10.1016/j.eplepsyres.2017.01.012. View

15.

Dravet C . The core Dravet syndrome phenotype. Epilepsia. 2011; 52 Suppl 2:3-9. DOI: 10.1111/j.1528-1167.2011.02994.x. View

16.

Ishii A, Watkins J, Chen D, Hirose S, Hammer M . Clinical implications of SCN1A missense and truncation variants in a large Japanese cohort with Dravet syndrome. Epilepsia. 2016; 58(2):282-290. DOI: 10.1111/epi.13639. View

17.

Musto E, Gardella E, Moller R . Recent advances in treatment of epilepsy-related sodium channelopathies. Eur J Paediatr Neurol. 2020; 24:123-128. DOI: 10.1016/j.ejpn.2019.12.009. View

18.

Myers K, Burgess R, Afawi Z, Damiano J, Berkovic S, Hildebrand M . De novo SCN1A pathogenic variants in the GEFS+ spectrum: Not always a familial syndrome. Epilepsia. 2017; 58(2):e26-e30. DOI: 10.1111/epi.13649. View

19.

OReilly H, Eltze C, Bennett K, Verhaert K, Webb R, Merrett A . Cognitive outcomes following epilepsy in infancy: A longitudinal community-based study. Epilepsia. 2018; 59(12):2240-2248. DOI: 10.1111/epi.14589. View

20.

Verheyen K, Wyers L, Del Felice A, Schoonjans A, Ceulemans B, Van de Walle P . Independent walking and cognitive development in preschool children with Dravet syndrome. Dev Med Child Neurol. 2020; 63(4):472-479. DOI: 10.1111/dmcn.14738. View